Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Payables (2020 - 2025)

Bio Essence has reported Payables over the past 6 years, most recently at $37385.0 for Q4 2025.

  • Quarterly results put Payables at $37385.0 for Q4 2025, up 110.76% from a year ago — trailing twelve months through Dec 2025 was $37385.0 (up 110.76% YoY), and the annual figure for FY2025 was $37385.0, up 110.76%.
  • Payables for Q4 2025 was $37385.0 at Bio Essence, up from $5725.0 in the prior quarter.
  • Over the last five years, Payables for BIOE hit a ceiling of $500914.0 in Q1 2021 and a floor of $5725.0 in Q3 2025.
  • Median Payables over the past 5 years was $77081.0 (2022), compared with a mean of $117812.2.
  • Biggest five-year swings in Payables: surged 136388.83% in 2021 and later plummeted 94.73% in 2025.
  • Bio Essence's Payables stood at $96141.0 in 2021, then crashed by 53.36% to $44844.0 in 2022, then plummeted by 51.19% to $21889.0 in 2023, then decreased by 18.96% to $17738.0 in 2024, then soared by 110.76% to $37385.0 in 2025.
  • The last three reported values for Payables were $37385.0 (Q4 2025), $5725.0 (Q3 2025), and $17658.0 (Q2 2025) per Business Quant data.